Back to medications
Medication monograph

atezolizumab

PD-L1 Inhibitors (Monoclonal Antibodies)Immunotherapy AgentsAntineoplastic AgentsProgrammed Death Receptor-1 Blocking AntibodyAntineoplastic Agents

Clinical reference

Product monograph

TECENTRIQ- atezolizumab injection, solution

Brands & formulations

Family members

TECENTRIQ

Marketed
1200 MGINTRAVENOUSSOLUTION[ "atezolizumab" ]
Product monograph

TECENTRIQ

Marketed
840 MGINTRAVENOUSSOLUTION[ "atezolizumab" ]
Product monograph

TECENTRIQ SC

Marketed
125 MGSUBCUTANEOUSSOLUTION[ "atezolizumab" ]
Product monograph

Classification

Chemical class
PD-L1 Inhibitors (Monoclonal Antibodies)
Clinical class
Immunotherapy Agents, Antineoplastic Agents
Banks class
Programmed Death Receptor-1 Blocking Antibody
AHFS family
Antineoplastic Agents